KNOWLEDGE

Medical Publications

22.04.2025
Shifts in treatment initiation patterns among newly diagnosed multiple sclerosis patients in Germany: a claims data analysis from 2017 to 2022
One of the key insights from this claims‑data study is the changing “time‑to‑therapy” clock for newly diagnosed MS patients in Germany. Early starts are climbing in some groups, while others see mounting delays - especially those with progressive onset. Dive in to uncover what’s driving the shift an...
Multiple Sclerosis Market Insights
Read publication
22.04.2025
Disparities in patient share and characteristics between disease-modifying therapy-treated and - untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022
One of the key insights from the study is the striking proportion of MS patients in Germany who remain untreated with disease-modifying therapies—despite available options. The data reveal notable differences tied to age, MS type, and geography, alongside contrasting patterns in healthcare utilizati...
Multiple Sclerosis Market Insights
Read publication
19.03.2025
Real-world evidence from Germany and the United States: Treatment initiation on low-efficacy versus high-efficacy therapies in patients with multiple sclerosis
Real-world evidence from Germany and the US shows that initiating MS treatment with high-efficacy therapies reduces the need for switching treatments—unlocking more stable, effective long-term disease management and transforming patient outcomes. By Steffeni Papukchieva, Hyung-Do Kim, Ann-Sophie Str...
Real-World Evidence Multiple Sclerosis
Read publication

Stay informed on new healthcare insights!

Subscribe to our newsletter and never miss out on the latest advancements, insights, and events.

We are at the dawn of a new healthcare era.

Get a demo